Therapeutic Potential of Translational Readthrough at Disease‐Associated Premature Termination Codons From Tumor Suppressor Genes
IUBMB Life · 2025
DOI: 10.1002/iub.70018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift IUBMB Life, 2025. Verfasst von Leire Torices und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biobizkaia Health Research Institute, Barakaldo, Spain. Hauptthemen laut MEDLINE: Codon, Nonsense, Genes, Tumor Suppressor, Protein Biosynthesis, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIBERER.
Abstract (Originalsprache)
Tumor suppressor genes are frequently targeted by mutations introducing premature termination codons (PTC) in the protein coding sequence, both in sporadic cancers and in the germline of patients with cancer predisposition syndromes. These mutations have a high pathogenic impact since they generate C‐terminal truncated proteins with altered stability and function. In addition, PTC mutations trigger transcript degradation by nonsense‐mediated mRNA decay. Suppression of PTC by translational readthrough restores protein biosynthesis and stabilizes the PTC‐targeted mRNA, making a suitable therapeutic approach the reconstitution of active full‐length tumor suppressor proteins by pharmacologically‐induced translational readthrough. Here, we review the recent advances in small molecule pharmacological induction of translational readthrough of disease‐associated PTC from tumor suppressor genes, and discuss the therapeutic potential of translational readthrough in specific groups of patients with hereditary syndromic cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biobizkaia Health Research Institute, Barakaldo, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Raras, CIBERER, ISCIII, Spain.
- Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
- Ikerbasque, The Basque Foundation for Science, Bilbao, Spain.
ORCID-Profile: Leire Torices, Caroline E Nunes-Xavier, Rafael Pulido
Förderung
- CIBERER
Zitieren
APA
Torices, L., Nunes-Xavier, C. E., & Pulido, R. (2025). Therapeutic Potential of Translational Readthrough at Disease‐Associated Premature Termination Codons From Tumor Suppressor Genes. IUBMB Life. https://doi.org/10.1002/iub.70018
Vancouver
Torices L, Nunes-Xavier CE, Pulido R. Therapeutic Potential of Translational Readthrough at Disease‐Associated Premature Termination Codons From Tumor Suppressor Genes. IUBMB Life. 2025. doi:10.1002/iub.70018
BibTeX
@article{Torices2025,
author = {Torices, Leire and Nunes-Xavier, Caroline E and Pulido, Rafael},
title = {Therapeutic Potential of Translational Readthrough at Disease‐Associated Premature Termination Codons From Tumor Suppressor Genes},
journal = {IUBMB Life},
year = {2025},
doi = {10.1002/iub.70018}
}
EUVIMED